Beth Guthmueller - Ferring Co, Rebiotix Inc

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

PUNCH CD3-OLS: a Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-Jslm (REBYOTA) in Adults with Recurrent Clostridioides Difficile Infection

Paul Feuerstadt, Teena Chopra,Whitfield Knapple,Nicholas W. Van Hise,Erik R. Dubberke, Brian Baggott,Beth Guthmueller,Lindy Bancke, Michael Gamborg,Theodore S. Steiner, Daniel Van Handel,Sahil Khanna

CLINICAL INFECTIOUS DISEASES (2024)

引用0浏览0WOS引用

Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides Difficile Infection : Subgroup Analysis of PUNCH CD2 and PUNCH CD3

Paul Feuerstadt,Carl V. Crawford, Xing Tan, Victoria Pokhilko,Lindy Bancke,Samson Ng,Beth Guthmueller,Monique R. Bidell,Glenn Tillotson,Stuart Johnson,Andrew M. Skinner

JOURNAL OF CLINICAL GASTROENTEROLOGYno. 8 (2024): 818-824

引用0浏览0WOS引用

Sa1901 EFFICACY AND SAFETY OF FECAL MICROBIOTA, LIVE-JSLM IN PARTICIPANTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION RECEIVING CONCOMITANT MEDICATIONS

Glenn S. Tillotson,Paul Feuerstadt,Travis J. Carlson,Beth Guthmueller, Anthony Martinez,Kelly Reveles

Gastroenterologyno. 5 (2024): S-571

引用0浏览0引用

Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), among Patients Exposed to Non-Clostridioides Difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study

Kelly R. Reveles,Anne J. Gonzales-Luna,Yoav Golan,Carolyn D. Alonso,Beth Guthmueller, Xing Tan,Monique R. Bidell, Victoria Pokhilko,Carl Crawford,Andrew M. Skinner

OPEN FORUM INFECTIOUS DISEASESno. 7 (2024)

引用0浏览0WOS引用

Safety of fecal microbiota, live-jslm (REBYOTA) in individuals with recurrent infection: data from five prospective clinical trials

Christine Lee,Thomas Louie,Lindy Bancke,Beth Guthmueller,Adam Harvey,Paul Feuerstadt,Sahil Khanna,Robert Orenstein,Erik R. Dubberke

Therapeutic Advances in Gastroenterology (2023)

引用0浏览0引用

Safety and efficacy of rbx2660 in reducing recurrent clostridioides difficile infection in immunocompromised participants

Erik R. Dubberke,Monika Fischer, Glenn S. Tillotson, Monique Bidell,Beth Guthmueller, Frederikke Hoeyer,Carolyn D. Alonso

GASTROENTEROLOGYno. 6 (2023): S142-S143

引用0浏览0引用

Safety of Fecal Microbiota, Live-Jslm (REBYOTA™) in Individuals with Recurrentclostridioides Difficileinfection: Data from Five Prospective Clinical Trials

Christine Lee,Thomas Louie,Lindy Bancke,Beth Guthmueller,Adam Charles Harvey,Paul Feuerstadt,Sahil Khanna,Robert Orenstein,Erik R. Dubberke

Therapeutic advances in gastroenterology (2023)

引用1浏览0引用

S195 Efficacy and Safety of Fecal Microbiota, Live-jslm in Older Participants with Recurrent Clostridioides Difficile Infection and Underlying Comorbidities: an Ad Hoc Analysis of an Open-Label, Phase 3 Study

Cirle A. Warren,Glenn Tillotson,Beth Guthmueller,Joan Thul,Paul Feuerstadt,Anne J Gonzales-Luna,Travis J Carlson

The American journal of gastroenterologyno. 10S (2023): S147-S147

引用0浏览0引用

Safety of fecal microbiota, live-jslm (REBYOTA^?) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials

Christine Lee,Thomas Louie,Lindy Bancke,Beth Guthmueller,Adam Harvey,Paul Feuerstadt,Sahil Khanna,Robert Orenstein,Erik R. R. Dubberke

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2023): 17562848231174277

引用2浏览0WOS引用

Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides Difficile Infection

Paul Feuerstadt,Carl V. Crawford, Xing Tan, Victoria Pokhilko,Lindy Bancke,Samson Ng,Beth Guthmueller,Monique R. Bidell, Glenn Tillotson,Stuart Johnson,Andrew M Skinner

Journal of clinical gastroenterology (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn